×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Angiodynamic Inc. (ANGO) NASDAQ

$5.88 0.18 (3.16%)

Market Cap: $227.17M

As of 03/28/24 03:59 PM EDT. Market closed.

(ANGO)

Angiodynamic Inc. (ANGO)
NASDAQ

$5.88
0.18 (3.16%)

Market Cap: $227.17M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, ... read more

founded in 1988 in queensbury, n.y., u.s., angiodynamics is today a nasdaq-listed public company. we are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. our diverse product line includes market-leading radiofrequency ablation and nanoknife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. angiodynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. angiodynamics believes it is well poised to continue that trend. looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patie read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
James Clemmer
Full Time Employees
981
CEO Compensation (Base)
$686,575
CEO Compensation (Total)
$3M
URL
Address
14 Plaza Dr, New York, Latham, 12110-2166.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
James Clemmer
Full Time Employees
981
CEO Compensation (Base)
$686,575
CEO Compensation (Total)
$3M
Address
14 Plaza Dr, New York, Latham, 12110-2166.
PRICE CHART FOR ANGIODYNAMIC INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.80
Previous Close
$5.70
Days Range
$5.45 - $5.71
52 week range
$5.27 - $11.38
Volume
428,799
Avg. Volume (30 days)
425,185
Market Cap
$227.17M
Dividend Yield
-
P/E
(16.09)
Shares Outstanding
39,855,191
Open
$5.80
Previous Close
$5.70
Days Range
$5.45 - $5.71
52 week range
$5.27 - $11.38
Volume
428,799
Avg. Volume (30 days)
425,185
Market Cap
$227.17M
Dividend Yield
-
P/E
(16.09)
Shares Outstanding
39,855,191
FINANCIAL STATEMENTS FOR ANGIODYNAMIC INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANGIODYNAMIC INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Trowbridge Stephen AEVP and CFOFeb 29, 2024 Option Exercise$4.671,9278,999128,901Mar 04, 2024, 08:49 PM
Trowbridge Stephen AEVP and CFOJul 19, 2023 Option Exercise$8.926,97562,217126,974Sep 21, 2023, 09:28 PM
Helsel DaveSVP Global Operations and R&DJul 19, 2023 Option Exercise$8.923,47731,01534,462Sep 21, 2023, 09:23 PM
Centea ScottSVP/GM, VITJul 19, 2023 Option Exercise$8.922,71624,22762,951Sep 21, 2023, 09:17 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 19, 2023 Option Exercise$8.923,10327,67953,016Sep 21, 2023, 09:12 PM
Clemmer James CPresident and CEOJul 19, 2023 Option Exercise$8.9234,296305,920564,446Sep 21, 2023, 09:07 PM
Clemmer James CPresident and CEOJul 19, 2023 Option Exercise$8.9211,379101,501549,259Jul 26, 2023, 09:32 PM
Helsel DaveSVP Global Operations and R&DJul 19, 2023 Option Exercise$8.921,57514,04931,085Jul 26, 2023, 09:32 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 19, 2023 Option Exercise$8.921,40412,52450,005Jul 26, 2023, 09:32 PM
Centea ScottSVP/GM, VITJul 19, 2023 Option Exercise$8.921,23010,97260,313Jul 26, 2023, 09:32 PM
Trowbridge Stephen AEVP and CFOJul 19, 2023 Option Exercise$8.923,15928,178120,205Jul 26, 2023, 09:32 PM
Trowbridge Stephen AEVP and CFOJul 21, 2023 Option Exercise$8.656675,770114,595Jul 25, 2023, 07:07 PM
Trowbridge Stephen AEVP and CFOJul 20, 2023 Option Exercise$8.747176,267115,262Jul 25, 2023, 07:07 PM
Clemmer James CPresident and CEOJul 21, 2023 Option Exercise$8.653,37229,168529,066Jul 25, 2023, 07:07 PM
Clemmer James CPresident and CEOJul 20, 2023 Option Exercise$8.742,98226,063532,438Jul 25, 2023, 07:07 PM
Helsel DaveSVP Global Operations and R&DJul 20, 2023 Option Exercise$8.743322,90228,654Jul 25, 2023, 07:07 PM
Helsel DaveSVP Global Operations and R&DJul 21, 2023 Option Exercise$8.653653,15728,289Jul 25, 2023, 07:07 PM
Centea ScottSVP/GM, VITJul 21, 2023 Option Exercise$8.652552,20658,128Jul 25, 2023, 07:06 PM
Centea ScottSVP/GM, VITJul 20, 2023 Option Exercise$8.743332,91058,383Jul 25, 2023, 07:06 PM
Piccinini LauraSVP InternationalJul 21, 2023 Option Exercise$8.654133,57219,093Jul 25, 2023, 07:06 PM
Piccinini LauraSVP InternationalJul 20, 2023 Option Exercise$8.746165,38419,506Jul 25, 2023, 07:06 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 21, 2023 Option Exercise$8.653953,41747,509Jul 25, 2023, 07:06 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 20, 2023 Option Exercise$8.743593,13847,904Jul 25, 2023, 07:06 PM
Trowbridge Stephen AEVP and CFOJul 14, 2023 Option Exercise$9.631,36213,11687,664Jul 18, 2023, 08:13 PM
Trowbridge Stephen AEVP and CFOJul 17, 2023 Option Exercise$9.563763,59587,288Jul 18, 2023, 08:13 PM
Clemmer James CPresident and CEOJul 17, 2023 Option Exercise$9.562,26221,625443,239Jul 18, 2023, 08:13 PM
Clemmer James CPresident and CEOJul 14, 2023 Option Exercise$9.634,90647,245445,501Jul 18, 2023, 08:13 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 17, 2023 Option Exercise$9.562792,66736,879Jul 18, 2023, 08:13 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 14, 2023 Option Exercise$9.635965,73937,158Jul 18, 2023, 08:13 PM
Centea ScottSVP/GM, VITJul 14, 2023 Option Exercise$9.635174,97948,479Jul 18, 2023, 08:13 PM
Centea ScottSVP/GM, VITJul 17, 2023 Option Exercise$9.563513,35648,128Jul 18, 2023, 08:13 PM
Helsel DaveSVP Global Operations and R&DJul 17, 2023 Option Exercise$9.563132,99218,197Jul 18, 2023, 08:13 PM
Helsel DaveSVP Global Operations and R&DJul 14, 2023 Option Exercise$9.636796,53918,510Jul 18, 2023, 08:13 PM
Piccinini LauraSVP InternationalJun 01, 2023 Option Exercise$9.641,40013,4965,954Jun 02, 2023, 03:36 PM
Trowbridge Stephen AEVP and CFOFeb 03, 2023 Option Exercise$13.435557,45489,026Feb 07, 2023, 04:02 PM
ROSENZWEIG RICHARD CSVP and General CounselFeb 01, 2023 Option Exercise$13.361,13715,19015,730Feb 07, 2023, 04:00 PM
Helsel DaveSVP Global Operations and R&DJan 31, 2023 Sale$12.954,63359,99719,189Feb 01, 2023, 04:07 PM
Trowbridge Stephen AEVP and CFOOct 12, 2022 Buy$13.821,08314,96789,581Oct 12, 2022, 05:23 PM
Clemmer James CPresident and CEOOct 10, 2022 Buy$15.0010,000150,000450,407Oct 11, 2022, 04:06 PM
Helsel DaveSVP Global Operations and R&DJul 29, 2022 Sale$22.445,000112,20023,822Aug 01, 2022, 04:19 PM
JOHNSON WESLEYDirectorJul 15, 2022 Option Exercise$21.324,50596,04781,221Jul 18, 2022, 04:16 PM
JOHNSON WESLEYDirectorJul 15, 2022 Option Exercise$15.956,02296,05185,726Jul 18, 2022, 04:16 PM
Trowbridge Stephen AEVP and CFOJul 15, 2022 Option Exercise$21.3212,398264,32580,537Jul 18, 2022, 04:13 PM
Trowbridge Stephen AEVP and CFOJul 15, 2022 Option Exercise$15.9514,758235,39092,935Jul 18, 2022, 04:13 PM
Meteny Dennis SDirectorJul 12, 2022 Option Exercise$20.024,79896,056115,918Jul 14, 2022, 04:15 PM
Meteny Dennis SDirectorJul 12, 2022 Option Exercise$15.956,02296,051120,716Jul 14, 2022, 04:15 PM
Helsel DaveSVP Global Operations and R&DJul 07, 2022 Option Exercise$20.541,22325,12025,131Jul 11, 2022, 06:20 AM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 07, 2022 Option Exercise$20.541,07822,14233,767Jul 11, 2022, 06:17 AM
Nighan Warren JRSVP Quality and RegulatoryJul 07, 2022 Option Exercise$20.5491918,87636,193Jul 11, 2022, 06:15 AM
Trowbridge Stephen AEVP and CFOJul 07, 2022 Option Exercise$20.541,50930,99578,177Jul 11, 2022, 06:12 AM
Clemmer James CPresident and CEOJul 07, 2022 Option Exercise$20.548,574176,110407,313Jul 11, 2022, 06:08 AM
Helsel DaveSVP Global Operations and R&DApr 28, 2022 Sale$22.443,51378,83222,874May 02, 2022, 06:04 AM
DONNELLY HOWARD WDirectorApr 20, 2022 Option Exercise$15.956,02296,051104,734Apr 21, 2022, 05:13 PM
JOHNSON WESLEYDirectorApr 12, 2022 Sale$23.261,29930,21579,704Apr 13, 2022, 04:07 PM
JOHNSON WESLEYDirectorApr 11, 2022 Sale$23.006,201142,62380,003Apr 13, 2022, 04:07 PM
Trowbridge Stephen AEVP and CFOFeb 03, 2022 Option Exercise$20.4858311,94075,498Feb 04, 2022, 04:38 PM
ROSENZWEIG RICHARD CSVP and General CounselFeb 01, 2022 Option Exercise$21.311,19425,44412,904Feb 03, 2022, 04:14 PM
Trowbridge Stephen AEVP and CFOJan 12, 2022 Buy$22.641,00022,64076,081Jan 12, 2022, 04:44 PM
Clemmer James CPresident and CEOJan 11, 2022 Buy$22.8410,000228,400390,764Jan 12, 2022, 04:35 PM
Centea ScottSr. VP/GM, Global VITOct 31, 2021 Option Exercise$29.3795327,99045,291Nov 05, 2021, 04:28 PM
Helsel DaveSVP Global Operations and R&DOct 20, 2021 Sale$27.973,49497,72726,387Oct 21, 2021, 04:50 PM
Centea ScottSr. VP/GM, Global VITOct 15, 2021 Option Exercise$16.7712,000201,24058,244Oct 18, 2021, 04:45 PM
Centea ScottSr. VP/GM, Global VITOct 15, 2021 Sale$27.9212,000335,04046,244Oct 18, 2021, 04:45 PM
Campbell Chad ThomasSVP/GM, Vascular AccessOct 05, 2021 Option Exercise$16.5910,748178,30942,489Oct 06, 2021, 06:39 PM
Campbell Chad ThomasSVP/GM, Vascular AccessOct 05, 2021 Sale$27.1510,748291,80831,741Oct 06, 2021, 06:39 PM
Campbell Chad ThomasSVP/GM, Vascular AccessAug 12, 2021 Option Exercise$27.293,13085,41831,741Aug 18, 2021, 07:11 AM
Clemmer James CPresident and CEOAug 12, 2021 Option Exercise$27.2921,532587,608378,163Aug 18, 2021, 07:08 AM
Trowbridge Stephen AEVP and CFOAug 12, 2021 Option Exercise$27.294,173113,88175,081Aug 18, 2021, 07:02 AM
Helsel DaveSVP Global Operations and R&DAug 12, 2021 Option Exercise$27.293,34791,34029,881Aug 18, 2021, 06:59 AM
Helsel DaveSVP Global Operations and R&DAug 12, 2021 Option Exercise$27.2978821,50523,719Aug 17, 2021, 06:50 AM
Clemmer James CPresident and CEOAug 12, 2021 Option Exercise$27.299,021246,183369,533Aug 17, 2021, 06:49 AM
Campbell Chad ThomasSVP/GM, Vascular AccessAug 12, 2021 Option Exercise$27.2970219,15828,354Aug 17, 2021, 06:48 AM
Trowbridge Stephen AEVP and CFOAug 12, 2021 Option Exercise$27.291,23133,59470,308Aug 17, 2021, 06:23 AM
Meteny Dennis SDirectorJul 28, 2021 Option Exercise$26.433,17183,810114,694Jul 30, 2021, 06:31 PM
Meteny Dennis SDirectorJul 28, 2021 Option Exercise$14.645,72683,829117,865Jul 30, 2021, 06:31 PM
JOHNSON WESLEYDirectorJul 28, 2021 Option Exercise$26.433,17183,81086,204Jul 30, 2021, 06:27 PM
JOHNSON WESLEYDirectorJul 28, 2021 Option Exercise$14.645,72683,82989,375Jul 30, 2021, 06:27 PM
Centea ScottSr. VP/GM, Global VITJul 26, 2021 Option Exercise$26.1041910,93646,244Jul 27, 2021, 07:05 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 26, 2021 Option Exercise$26.103188,30026,661Jul 27, 2021, 07:01 PM
Trowbridge Stephen AEVP and CFOJul 26, 2021 Option Exercise$26.103539,21368,308Jul 27, 2021, 07:01 PM
Clemmer James CPresident and CEOJul 26, 2021 Option Exercise$26.102,10554,941359,167Jul 27, 2021, 06:43 PM
Trowbridge Stephen AEVP and CFOJul 17, 2021 Option Exercise$24.763548,76561,653Jul 23, 2021, 06:53 PM
Trowbridge Stephen AEVP and CFOJul 14, 2021 Option Exercise$26.431,28433,93662,007Jul 23, 2021, 06:53 PM
Trowbridge Stephen AEVP and CFOJul 18, 2021 Option Exercise$24.764009,90461,253Jul 23, 2021, 06:53 PM
Helsel DaveSVP Global Operations and R&DJul 18, 2021 Option Exercise$24.7641710,32517,764Jul 23, 2021, 06:50 PM
Helsel DaveSVP Global Operations and R&DJul 17, 2021 Option Exercise$24.762947,27918,181Jul 23, 2021, 06:50 PM
Helsel DaveSVP Global Operations and R&DJul 14, 2021 Option Exercise$26.4364016,91518,475Jul 23, 2021, 06:50 PM
Centea ScottSVP/GM, VITJul 14, 2021 Option Exercise$26.4350013,21544,504Jul 23, 2021, 06:47 PM
Centea ScottSVP/GM, VITJul 18, 2021 Option Exercise$24.763448,51743,821Jul 23, 2021, 06:47 PM
Centea ScottSVP/GM, VITJul 17, 2021 Option Exercise$24.763398,39444,165Jul 23, 2021, 06:47 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 18, 2021 Option Exercise$24.763007,42822,591Jul 23, 2021, 06:45 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 17, 2021 Option Exercise$24.762626,48722,891Jul 23, 2021, 06:45 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 14, 2021 Option Exercise$26.4357115,09223,153Jul 23, 2021, 06:45 PM
Clemmer James CPresident and CEOJul 14, 2021 Option Exercise$26.434,622122,159338,697Jul 23, 2021, 06:42 PM
Clemmer James CPresident and CEOJul 18, 2021 Option Exercise$24.761,48336,719335,083Jul 23, 2021, 06:42 PM
Clemmer James CPresident and CEOJul 17, 2021 Option Exercise$24.762,13152,764336,566Jul 23, 2021, 06:42 PM
Helsel DaveSVP Global Operations and R&DApr 14, 2021 Sale$23.933,50083,75519,115Apr 15, 2021, 04:20 PM
DONNELLY HOWARD WDirectorApr 01, 2021 Option Exercise$23.153,62183,82692,974Apr 05, 2021, 05:53 PM
DONNELLY HOWARD WDirectorApr 01, 2021 Option Exercise$14.645,72683,82996,595Apr 05, 2021, 05:53 PM
Trowbridge Stephen AEVP and CFOFeb 03, 2021 Option Exercise$19.2452710,13959,746Feb 04, 2021, 04:27 PM
JOHNSON WESLEYDirectorJan 20, 2021 Sale$18.536,500120,44577,911Jan 21, 2021, 10:15 AM
Helsel DaveSVP Global Operations and R&DDec 18, 2020 Option Exercise$14.2973310,47522,615Dec 21, 2020, 06:05 PM
Centea ScottSVP/GM, VITOct 31, 2020 Option Exercise$10.628499,01645,004Nov 03, 2020, 04:22 PM
Trowbridge Stephen AEVP and CFOAug 11, 2020 Buy$9.381,0139,50260,273Aug 12, 2020, 04:14 PM
Clemmer James CPresident and CEOJul 31, 2020 Buy$8.2640,000330,400343,319Aug 03, 2020, 05:27 PM
Trowbridge Stephen AEVP and CFOJul 27, 2020 Option Exercise$8.802922,57059,260Jul 28, 2020, 04:43 PM
Trowbridge Stephen AEVP and CFOJul 26, 2020 Option Exercise$8.803142,76359,552Jul 28, 2020, 04:43 PM
Clemmer James CPresident and CEOJul 26, 2020 Option Exercise$8.801,87616,509305,118Jul 28, 2020, 04:38 PM
Clemmer James CPresident and CEOJul 27, 2020 Option Exercise$8.801,79915,831303,319Jul 28, 2020, 04:38 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 27, 2020 Option Exercise$8.802592,27923,724Jul 28, 2020, 04:27 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 26, 2020 Option Exercise$8.802832,49023,983Jul 28, 2020, 04:27 PM
Trowbridge Stephen AEVP and CFOJul 18, 2020 Option Exercise$9.214003,68460,018Jul 21, 2020, 07:36 PM
Trowbridge Stephen AEVP and CFOJul 17, 2020 Option Exercise$9.463543,34960,266Jul 21, 2020, 07:36 PM
Helsel DaveSVP Global Operations and R&DJul 17, 2020 Option Exercise$9.462542,40323,708Jul 21, 2020, 07:34 PM
Helsel DaveSVP Global Operations and R&DJul 18, 2020 Option Exercise$9.213623,33423,501Jul 21, 2020, 07:34 PM
Clemmer James CPresident and CEOJul 18, 2020 Option Exercise$9.211,48313,658306,994Jul 21, 2020, 07:33 PM
Clemmer James CPresident and CEOJul 17, 2020 Option Exercise$9.462,13120,159308,477Jul 21, 2020, 07:33 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 18, 2020 Option Exercise$9.213002,76324,342Jul 21, 2020, 07:31 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 17, 2020 Option Exercise$9.462622,47924,566Jul 21, 2020, 07:31 PM
Campbell Chad ThomasSVP/GM, Vascular AccessMay 23, 2020 Option Exercise$11.218269,25918,102May 27, 2020, 08:56 PM
Clemmer James CPresident and CEOApr 04, 2020 Option Exercise$10.234,24543,426256,173Apr 07, 2020, 04:11 PM
Boucher Brent J.SVP and GM of OncologyFeb 12, 2020 Option Exercise$12.994906,36515,416Feb 18, 2020, 07:03 PM
Boucher Brent J.SVP and GM of OncologyJan 17, 2020 Option Exercise$15.484907,58515,906Jan 21, 2020, 04:17 PM
Helsel DaveSVP Global Operations and R&DDec 18, 2019 Option Exercise$15.5773611,46016,422Dec 20, 2019, 05:14 PM
Clemmer James CPresident and CEOOct 25, 2019 Buy$14.1915,000212,850260,418Oct 28, 2019, 08:13 AM
Greiner MichaelEVP and CFOAug 18, 2019 Option Exercise$19.1082615,77733,438Aug 20, 2019, 06:52 PM
Trowbridge Stephen ASVP and General CounselJul 12, 2019 Option Exercise$21.681,18525,69140,123Aug 20, 2019, 06:14 AM
Greiner MichaelEVP and CFOJul 12, 2019 Option Exercise$21.683,44074,57934,264Aug 20, 2019, 06:08 AM
Simpson Robert ArthurSVP/GM, Global VascularJul 12, 2019 Option Exercise$21.685,158111,82525,883Aug 19, 2019, 10:00 PM
Clemmer James CPresident and CEOJul 12, 2019 Option Exercise$21.6896,1402,084,315245,418Aug 19, 2019, 09:59 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 12, 2019 Option Exercise$21.681,05022,76421,052Aug 19, 2019, 09:58 PM
JOHNSON WESLEYDirectorAug 06, 2019 Option Exercise$19.833,58171,01169,088Aug 09, 2019, 05:41 PM
JOHNSON WESLEYDirectorAug 06, 2019 Option Exercise$10.686,65071,02272,669Aug 09, 2019, 05:41 PM
Clemmer James CPresident and CEOJul 26, 2019 Option Exercise$20.891,82638,145143,310Aug 02, 2019, 04:33 PM
Clemmer James CPresident and CEOJul 27, 2019 Option Exercise$20.911,75236,634141,558Aug 02, 2019, 04:33 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 27, 2019 Option Exercise$20.912525,26918,928Aug 02, 2019, 04:31 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 26, 2019 Option Exercise$20.892765,76619,180Aug 02, 2019, 04:31 PM
Simpson Robert ArthurSVP/GM, Global VascularJul 26, 2019 Option Exercise$20.893096,45515,441Aug 02, 2019, 04:29 PM
Trowbridge Stephen ASVP and General CounselJul 27, 2019 Option Exercise$20.912855,95937,723Aug 02, 2019, 04:26 PM
Trowbridge Stephen ASVP and General CounselJul 26, 2019 Option Exercise$20.893066,39238,008Aug 02, 2019, 04:26 PM
Trowbridge Stephen ASVP and General CounselJul 22, 2019 Option Exercise$21.383557,59038,314Aug 02, 2019, 04:26 PM
Greiner MichaelEVP and CFOJul 26, 2019 Option Exercise$20.8951110,67527,304Aug 02, 2019, 04:22 PM
Greiner MichaelEVP and CFOJul 18, 2019 Option Exercise$21.5357612,40127,987Jul 25, 2019, 04:59 PM
Clemmer James CPresident and CEOJul 18, 2019 Option Exercise$21.531,44431,089145,136Jul 25, 2019, 04:56 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 18, 2019 Option Exercise$21.532926,28719,530Jul 25, 2019, 04:54 PM
Trowbridge Stephen ASVP and General CounselJul 22, 2019 Option Exercise$21.383557,59038,669Jul 25, 2019, 04:51 PM
Trowbridge Stephen ASVP and General CounselJul 18, 2019 Option Exercise$21.533898,37539,172Jul 25, 2019, 04:51 PM
Boucher Brent J.SVP and GM of OncologyJul 18, 2019 Option Exercise$21.533738,03116,544Jul 25, 2019, 04:48 PM
Helsel DaveSVP Global Operations and R&DJul 18, 2019 Option Exercise$21.534058,72017,330Jul 25, 2019, 04:46 PM
Simpson Robert ArthurSVP/GM, Global VascularJul 18, 2019 Option Exercise$21.533928,44015,898Jul 25, 2019, 04:42 PM
GOLD JEFFREYDirectorJul 12, 2019 Option Exercise$21.683,27671,02476,583Jul 18, 2019, 04:15 PM
GOLD JEFFREYDirectorJul 12, 2019 Option Exercise$10.686,65071,02279,859Jul 18, 2019, 04:15 PM
Gould Kevin JDirectorJul 16, 2019 Option Exercise$11.3213,650154,46268,774Jul 18, 2019, 04:12 PM
Gould Kevin JDirectorJul 16, 2019 Sale$21.4513,650292,79355,124Jul 18, 2019, 04:12 PM
Meteny Dennis SDirectorJun 28, 2019 Option Exercise$19.693,60771,02284,021Jul 16, 2019, 04:26 PM
Meteny Dennis SDirectorJun 28, 2019 Option Exercise$10.686,65071,02287,628Jul 16, 2019, 04:26 PM
Meteny Dennis SDirectorMay 31, 2019 Option Exercise$18.793,78071,02683,848Jul 03, 2019, 05:58 PM
Meteny Dennis SDirectorMay 31, 2019 Option Exercise$10.686,65071,02287,628Jul 03, 2019, 05:58 PM
Campbell Chad ThomasSVP/GM, Vascular AccessMay 23, 2019 Option Exercise$19.1585816,43116,650May 24, 2019, 12:53 PM
Trowbridge Stephen ASVP and General CounselApr 24, 2019 Option Exercise$20.641,31927,22435,235Apr 25, 2019, 08:21 PM
Clemmer James CPresident and CEOApr 04, 2019 Option Exercise$22.954,23297,124121,476Apr 08, 2019, 04:09 PM
Boucher Brent J.SVP and GM of OncologyFeb 12, 2019 Option Exercise$22.9049011,22113,543Feb 14, 2019, 06:14 PM
Simpson Robert ArthurSVP/GM, Global VascularJan 31, 2019 Option Exercise$21.1098120,69916,142Feb 01, 2019, 04:24 PM
Greiner MichaelEVP and CFONov 07, 2018 Sale$21.531,93941,74720,731Nov 08, 2018, 04:06 PM
Trowbridge Stephen ASVP and General CounselJul 12, 2018 Option Exercise$20.501,17524,08838,935Aug 22, 2018, 07:05 PM
Trowbridge Stephen ASVP and General CounselJul 27, 2018 Option Exercise$21.422856,10536,554Jul 30, 2018, 06:57 PM
Clemmer James CPresident and CEOJul 27, 2018 Option Exercise$21.421,75237,528125,708Jul 30, 2018, 06:56 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 27, 2018 Option Exercise$21.422525,39817,508Jul 30, 2018, 06:53 PM
Trowbridge Stephen ASVP and General CounselJul 26, 2018 Option Exercise$21.883066,69536,839Jul 27, 2018, 08:13 PM
Trowbridge Stephen ASVP and General CounselJul 25, 2018 Option Exercise$21.503918,40737,145Jul 27, 2018, 08:13 PM
Trowbridge Stephen ASVP and General CounselJul 22, 2018 Option Exercise$21.673557,69337,536Jul 27, 2018, 08:13 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 26, 2018 Option Exercise$21.882766,03917,760Jul 27, 2018, 08:08 PM
Greiner MichaelEVP and CFOJul 26, 2018 Option Exercise$21.8851111,18122,670Jul 27, 2018, 08:01 PM
Clemmer James CPresident and CEOJul 26, 2018 Option Exercise$21.881,82639,953127,460Jul 27, 2018, 07:58 PM
Simpson Robert ArthurSVP/GM, Global VascularJul 26, 2018 Option Exercise$21.883086,73917,123Jul 27, 2018, 07:55 PM
GOLD JEFFREYDirectorJul 06, 2018 Option Exercise$23.654,00494,69566,902Jul 10, 2018, 06:44 PM
GOLD JEFFREYDirectorJul 06, 2018 Option Exercise$13.537,00094,71070,906Jul 10, 2018, 06:44 PM
Meteny Dennis SDirectorJun 21, 2018 Option Exercise$22.408,456189,41474,671Jun 25, 2018, 04:30 PM
Meteny Dennis SDirectorJun 21, 2018 Option Exercise$13.5314,000189,42083,127Jun 25, 2018, 04:30 PM
DONNELLY HOWARD WDirectorJun 21, 2018 Option Exercise$22.403,17171,03062,182Jun 25, 2018, 04:26 PM
DONNELLY HOWARD WDirectorJun 21, 2018 Option Exercise$10.686,65071,02265,353Jun 25, 2018, 04:26 PM
GOLD JEFFREYDirectorJun 21, 2018 Option Exercise$22.404,22894,70763,906Jun 25, 2018, 04:23 PM
GOLD JEFFREYDirectorJun 21, 2018 Option Exercise$13.537,00094,71068,134Jun 25, 2018, 04:23 PM
JOHNSON WESLEYDirectorJun 22, 2018 Option Exercise$22.778,319189,42452,655Jun 25, 2018, 04:20 PM
JOHNSON WESLEYDirectorJun 22, 2018 Option Exercise$13.5314,000189,42060,974Jun 25, 2018, 04:20 PM
Campbell Chad ThomasSVP/GM, Vascular AccessMay 23, 2018 Option Exercise$20.3782716,84614,497May 24, 2018, 08:58 PM
Trowbridge Stephen ASVP and General CounselApr 24, 2018 Option Exercise$19.761,28025,29333,172Apr 25, 2018, 04:57 PM
Simpson Robert ArthurSVP/GM, Global VascularJan 31, 2018 Option Exercise$17.411,05618,38512,683Feb 02, 2018, 03:12 PM
DONNELLY HOWARD WDirectorNov 21, 2017 Option Exercise$17.4210,873189,40858,703Nov 22, 2017, 01:48 PM
DONNELLY HOWARD WDirectorNov 21, 2017 Option Exercise$13.5314,000189,42069,576Nov 22, 2017, 01:48 PM
Richard StarkSVP, GM - OncologyNov 15, 2017 Option Exercise$11.4527,409313,81548,163Nov 17, 2017, 04:08 PM
Richard StarkSVP, GM - OncologyNov 15, 2017 Sale$16.2927,409446,49320,754Nov 17, 2017, 04:08 PM
Gould Kevin JDirectorSep 12, 2017 Option Exercise$18.0930,247547,16848,817Sep 14, 2017, 03:24 PM
Gould Kevin JDirectorSep 12, 2017 Option Exercise$14.0339,000547,17065,064Sep 14, 2017, 03:24 PM
Trowbridge Stephen ASVP and General CounselAug 06, 2017 Option Exercise$16.564958,19734,452Aug 08, 2017, 05:49 PM
JOHNSON WESLEYDirectorJul 25, 2017 Option Exercise$17.1212,879220,48848,095Aug 08, 2017, 05:48 PM
JOHNSON WESLEYDirectorJul 25, 2017 Option Exercise$15.7514,000220,50060,974Aug 08, 2017, 05:48 PM
Richard StarkSVP, GM - OncologyAug 06, 2017 Option Exercise$16.565028,31320,754Aug 08, 2017, 05:46 PM
Meteny Dennis SDirectorJul 25, 2017 Option Exercise$17.1212,879220,48870,248Aug 08, 2017, 05:44 PM
Meteny Dennis SDirectorJul 25, 2017 Option Exercise$15.7514,000220,50083,127Aug 08, 2017, 05:44 PM
Clemmer James CPresident and CEOJul 27, 2017 Option Exercise$16.361,95832,033111,817Jul 28, 2017, 05:38 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 27, 2017 Option Exercise$16.362824,61415,324Jul 28, 2017, 05:35 PM
GOLD JEFFREYDirectorJul 25, 2017 Option Exercise$17.1212,879220,48853,158Jul 28, 2017, 03:47 PM
GOLD JEFFREYDirectorJul 25, 2017 Option Exercise$15.7514,000220,50066,037Jul 28, 2017, 03:47 PM
Richard StarkSVP, GM - OncologyJul 25, 2017 Option Exercise$17.124327,39617,608Jul 28, 2017, 03:15 PM
Richard StarkSVP, GM - OncologyJul 22, 2017 Option Exercise$16.803936,60218,040Jul 28, 2017, 03:15 PM
Trowbridge Stephen ASVP and General CounselJul 25, 2017 Option Exercise$17.124377,48131,242Jul 28, 2017, 03:05 PM
Trowbridge Stephen ASVP and General CounselJul 22, 2017 Option Exercise$16.803976,67031,679Jul 28, 2017, 03:05 PM
REED JAN STERNDirectorJul 24, 2017 Buy$16.003165,056316Jul 25, 2017, 02:33 PM
DONNELLY HOWARD WDirectorJul 21, 2017 Buy$15.725,00078,60047,600Jul 21, 2017, 09:46 PM
Clemmer James CPresident and CEOJul 21, 2017 Buy$15.795,00078,95091,683Jul 21, 2017, 06:43 PM
Clemmer James CPresident and CEOJul 20, 2017 Buy$15.6420,000312,80086,683Jul 21, 2017, 06:43 PM
DONNELLY HOWARD WDirectorJun 19, 2017 Option Exercise$16.2813,544220,49642,600Jun 21, 2017, 09:42 PM
DONNELLY HOWARD WDirectorJun 19, 2017 Option Exercise$15.7514,000220,50056,144Jun 21, 2017, 09:42 PM
Campbell Chad ThomasSVP/GM, Vascular AccessMay 23, 2017 Option Exercise$15.8278812,46612,264May 25, 2017, 06:07 PM
Trowbridge Stephen ASVP and General CounselApr 24, 2017 Option Exercise$15.781,58525,01132,076Apr 25, 2017, 04:14 PM
Burgstahler David FDirectorApr 12, 2017 Sale$16.002,350,00037,600,0001,446,413Apr 14, 2017, 04:48 PM
Avista Capital Partners GP, LLC10% OwnerApr 12, 2017 Sale$16.002,350,00037,600,0001,446,413Apr 14, 2017, 04:40 PM
Clemmer James CPresident and CEOApr 04, 2017 Option Exercise$17.064,50876,90666,683Apr 10, 2017, 02:00 PM
LaPorte SteveDirectorJan 13, 2017 Option Exercise$17.9214,000250,88034,201Jan 17, 2017, 02:34 PM
LaPorte SteveDirectorJan 13, 2017 Option Exercise$15.7514,000220,50048,201Jan 17, 2017, 02:34 PM
Burgstahler David FDirectorNov 18, 2016 Option Exercise$15.68408,7066,408,510765,590Nov 22, 2016, 04:21 PM
Burgstahler David FDirectorNov 18, 2016 Sale$15.682,091,29432,791,4912,903,360Nov 22, 2016, 04:21 PM
Avista Capital Partners GP, LLC10% OwnerNov 18, 2016 Option Exercise$15.68408,7066,408,510765,590Nov 22, 2016, 04:20 PM
Avista Capital Partners GP, LLC10% OwnerNov 18, 2016 Sale$15.682,091,29432,791,4912,903,360Nov 22, 2016, 04:20 PM
Meteny Dennis SDirectorAug 31, 2016 Option Exercise$16.549,642159,47961,151Sep 06, 2016, 06:54 PM
Meteny Dennis SDirectorAug 31, 2016 Option Exercise$13.2912,000159,48070,793Sep 06, 2016, 06:54 PM
GOLD JEFFREYDirectorAug 31, 2016 Option Exercise$16.549,642159,47952,037Sep 06, 2016, 06:51 PM
GOLD JEFFREYDirectorAug 31, 2016 Option Exercise$13.2912,000159,48061,679Sep 06, 2016, 06:51 PM
Trowbridge Stephen ASVP and General CounselJul 11, 2016 Option Exercise$14.481,69824,58733,661Aug 18, 2016, 09:15 PM
Trowbridge Stephen ASVP and General CounselAug 08, 2016 Option Exercise$15.494977,69930,783Aug 09, 2016, 05:25 PM
Burgstahler David FDirectorAug 05, 2016 Sale$14.622,250,00032,895,0004,453,305Aug 05, 2016, 04:42 PM
Avista Capital Partners GP, LLC10% OwnerAug 05, 2016 Sale$14.622,241,00032,763,4204,453,305Aug 05, 2016, 04:39 PM
Trowbridge Stephen ASVP and General CounselJul 25, 2016 Option Exercise$16.494397,23927,833Jul 27, 2016, 05:13 PM
Trowbridge Stephen ASVP and General CounselJul 22, 2016 Option Exercise$16.523996,59128,272Jul 26, 2016, 06:19 PM
DONNELLY HOWARD WDirectorJul 15, 2016 Option Exercise$16.209,844159,47337,081Jul 18, 2016, 08:16 PM
DONNELLY HOWARD WDirectorJul 15, 2016 Option Exercise$13.2912,000159,48046,925Jul 18, 2016, 08:16 PM
JOHNSON WESLEYDirectorJul 15, 2016 Option Exercise$16.209,844159,47333,935Jul 18, 2016, 08:14 PM
JOHNSON WESLEYDirectorJul 15, 2016 Option Exercise$13.2912,000159,48043,779Jul 18, 2016, 08:14 PM
LaPorte SteveDirectorJul 13, 2016 Option Exercise$15.9410,005159,48029,138Jul 15, 2016, 07:25 PM
LaPorte SteveDirectorJul 13, 2016 Option Exercise$13.2912,000159,48039,143Jul 15, 2016, 07:25 PM
Greiner Charles RVP - Global FranchiseMay 06, 2016 Sale$12.313,50843,18320,910May 09, 2016, 04:05 PM
Trowbridge Stephen ASVP and General CounselApr 25, 2016 Option Exercise$12.231,35816,60828,671Apr 25, 2016, 06:59 PM
Trowbridge Stephen ASVP and General CounselApr 21, 2016 Sale$12.3310,500129,46532,469Apr 25, 2016, 06:59 PM
Trowbridge Stephen ASVP and General CounselApr 25, 2016 Sale$12.182,44029,71930,029Apr 25, 2016, 06:59 PM
SOTO JOHNSVP and CCOSep 10, 2015 Option Exercise$14.5181611,84022,452Sep 11, 2015, 08:39 PM
DEVIVO JOSEPHPresident and CEOSep 08, 2015 Option Exercise$14.522,32033,686198,451Sep 11, 2015, 08:36 PM
SOTO JOHNSVP and CCOAug 06, 2015 Option Exercise$15.914927,82823,268Aug 07, 2015, 04:51 PM
Trowbridge Stephen ASVP and General CounselAug 06, 2015 Option Exercise$15.914857,71642,969Aug 07, 2015, 04:49 PM
Greiner Charles RVP - Global FranchiseAug 06, 2015 Option Exercise$15.914657,39824,418Aug 07, 2015, 04:47 PM
Richard StarkSVP, GM - OncologyAug 06, 2015 Option Exercise$15.914777,58930,528Aug 07, 2015, 04:45 PM
Frost Mark TEVP and CFOAug 06, 2015 Option Exercise$15.9179712,68038,389Aug 07, 2015, 04:44 PM
DEVIVO JOSEPHPresident and CEOAug 06, 2015 Option Exercise$15.911,66026,411200,771Aug 07, 2015, 04:42 PM
Meteny Dennis SDirectorAug 05, 2015 Option Exercise$15.815,79591,61953,730Aug 07, 2015, 04:39 PM
Meteny Dennis SDirectorAug 05, 2015 Option Exercise$15.276,00091,62059,525Aug 07, 2015, 04:39 PM
JOHNSON WESLEYDirectorAug 05, 2015 Option Exercise$15.815,79591,61931,779Aug 06, 2015, 02:05 PM
JOHNSON WESLEYDirectorAug 05, 2015 Option Exercise$15.276,00091,62037,574Aug 06, 2015, 02:05 PM
GOLD JEFFREYDirectorAug 05, 2015 Option Exercise$15.815,79591,61944,616Aug 06, 2015, 01:58 PM
GOLD JEFFREYDirectorAug 05, 2015 Option Exercise$15.276,00091,62050,411Aug 06, 2015, 01:58 PM
LaPorte SteveDirectorAug 05, 2015 Option Exercise$15.815,79591,61927,143Aug 06, 2015, 01:54 PM
LaPorte SteveDirectorAug 05, 2015 Option Exercise$15.276,00091,62032,938Aug 06, 2015, 01:54 PM
Richard StarkSVP, GM - OncologyAug 03, 2015 Option Exercise$15.541,65225,67231,764Aug 05, 2015, 09:57 PM
DEVIVO JOSEPHPresident and CEOAug 03, 2015 Option Exercise$15.542,01431,298202,431Aug 05, 2015, 09:57 PM
Greiner Charles RVP - Global FranchiseAug 03, 2015 Option Exercise$15.541,19418,55524,576Aug 05, 2015, 09:48 PM
Greiner Charles RVP - Global FranchiseAug 05, 2015 Option Exercise$15.8113,793218,06724,883Aug 05, 2015, 09:48 PM
Greiner Charles RVP - Global FranchiseAug 05, 2015 Option Exercise$15.2714,100215,30738,676Aug 05, 2015, 09:48 PM
Trowbridge Stephen ASVP and General CounselAug 05, 2015 Option Exercise$15.815,67489,70643,454Aug 05, 2015, 09:47 PM
Trowbridge Stephen ASVP and General CounselAug 03, 2015 Option Exercise$15.541,31220,38843,735Aug 05, 2015, 09:47 PM
Trowbridge Stephen ASVP and General CounselAug 05, 2015 Option Exercise$15.275,80088,56649,128Aug 05, 2015, 09:47 PM
Frost Mark TEVP and CFOJul 27, 2015 Option Exercise$15.6369610,87839,186Jul 29, 2015, 08:57 PM
DEVIVO JOSEPHPresident and CEOJul 27, 2015 Option Exercise$15.632,79643,701204,445Jul 29, 2015, 08:56 PM
SOTO JOHNSVP and CCOJul 27, 2015 Option Exercise$15.635668,84723,760Jul 29, 2015, 08:55 PM
Greiner Charles RVP - Global FranchiseJul 27, 2015 Option Exercise$15.634116,42425,770Jul 29, 2015, 08:54 PM
Richard StarkSVP, GM - OncologyJul 27, 2015 Option Exercise$15.634216,58032,567Jul 29, 2015, 08:53 PM
Trowbridge Stephen ASVP and General CounselJul 27, 2015 Option Exercise$15.634286,69044,640Jul 29, 2015, 08:51 PM
DONNELLY HOWARD WDirectorJul 16, 2015 Option Exercise$15.276,00091,62029,659Jul 17, 2015, 07:02 PM
JOHNSON WESLEYDirectorJun 08, 2015 Option Exercise$16.554,64976,94126,308Jun 10, 2015, 05:47 PM
Richard StarkSVP, GM - OncologyFeb 13, 2015 Option Exercise$15.2718,100276,38746,801Feb 19, 2015, 04:20 PM
Richard StarkSVP, GM - OncologyFeb 13, 2015 Sale$18.5318,100335,39328,701Feb 19, 2015, 04:20 PM
Richard StarkSVP, GM - OncologyJan 28, 2015 Option Exercise$19.424198,13728,701Jan 29, 2015, 07:59 PM
Frost Mark TEVP and CFODec 01, 2014 Option Exercise$17.451,85632,38733,913Dec 02, 2014, 05:01 PM
Kapusta Matthew CSVP, Business DevelopmentNov 17, 2014 Option Exercise$16.851,39223,45530,062Nov 19, 2014, 04:08 PM
Greiner Charles RVP - Global FranchiseOct 20, 2014 Sale$15.633,29851,54822,055Oct 21, 2014, 06:21 PM
SOTO JOHNEVP and CCOSep 10, 2014 Option Exercise$13.3681610,90218,898Sep 11, 2014, 07:35 PM
DEVIVO JOSEPHPresident and CEOSep 08, 2014 Option Exercise$13.552,32031,436179,180Sep 10, 2014, 05:51 PM
GOLD JEFFREYDirectorJul 07, 2014 Option Exercise$15.905,40585,93932,952Aug 14, 2014, 09:19 PM
GOLD JEFFREYDirectorJul 07, 2014 Option Exercise$13.186,00079,08038,357Aug 14, 2014, 09:19 PM
Bourne George W. IVCTO and COOAug 06, 2014 Option Exercise$14.755748,46723,613Aug 08, 2014, 09:45 PM
Greiner Charles RVP - Global FranchiseAug 06, 2014 Option Exercise$14.754656,85925,353Aug 08, 2014, 09:43 PM
Greiner Charles RVP - Global FranchiseAug 03, 2014 Option Exercise$14.691,85127,19127,023Aug 08, 2014, 09:43 PM
Richard StarkSVP, GM - OncologyAug 06, 2014 Option Exercise$14.754777,03629,120Aug 08, 2014, 09:38 PM
Richard StarkSVP, GM - OncologyAug 03, 2014 Option Exercise$14.692,00929,51231,249Aug 08, 2014, 09:38 PM
Kapusta Matthew CSVP, Business DevelopmentAug 06, 2014 Option Exercise$14.755768,49630,704Aug 08, 2014, 09:35 PM
Kapusta Matthew CSVP, Business DevelopmentAug 03, 2014 Option Exercise$14.695307,78631,280Aug 08, 2014, 09:35 PM
DEVIVO JOSEPHPresident and CEOAug 06, 2014 Option Exercise$14.751,66024,485181,500Aug 08, 2014, 09:29 PM
DEVIVO JOSEPHPresident and CEOAug 03, 2014 Option Exercise$14.692,01429,586183,160Aug 08, 2014, 09:29 PM
Frost Mark TEVP and CFOAug 06, 2014 Option Exercise$14.7579711,75633,291Aug 08, 2014, 07:33 PM
SOTO JOHNSVP - Global Franchise LeaderAug 06, 2014 Option Exercise$14.755508,11319,714Aug 08, 2014, 07:09 PM
Bourne George W. IVCTO and COOMay 21, 2014 Option Exercise$14.1294813,38618,843May 23, 2014, 04:16 PM
Meteny Dennis SDirectorApr 14, 2014 Option Exercise$11.0015,500170,50042,066May 19, 2014, 04:15 PM
Kapusta Matthew CSVP, Business DevelopmentApr 14, 2014 Buy$13.901,00013,90027,005Apr 16, 2014, 02:14 PM
Richard StarkSVP, GM - OncologyJan 28, 2014 Option Exercise$16.673575,95126,888Jan 30, 2014, 02:04 PM
McGill StephenSVP, GM - InternationalJan 28, 2014 Option Exercise$16.671,17519,58720,715Jan 30, 2014, 02:01 PM
Bourne George W. IVCTO and COODec 17, 2013 Option Exercise$15.631632,54817,855Dec 18, 2013, 02:21 PM
Kapusta Matthew CSVP, Business DevelopmentNov 15, 2013 Option Exercise$15.621,39221,74323,158Nov 18, 2013, 05:02 PM
Greiner Charles RVP - Global FinanceNov 14, 2013 Option Exercise$13.184,37357,63627,501Nov 15, 2013, 05:23 PM
Greiner Charles RVP - Global FinanceNov 13, 2013 Sale$15.402,39236,84223,128Nov 15, 2013, 05:23 PM
Greiner Charles RVP - Global FinanceNov 14, 2013 Sale$15.464,37367,61123,128Nov 15, 2013, 05:23 PM
BUCCI VINCENTDirectorOct 18, 2013 Buy$15.205,00075,99086,696Oct 21, 2013, 12:03 PM
DONNELLY HOWARD WDirectorOct 17, 2013 Option Exercise$11.0020,000220,00035,850Oct 21, 2013, 12:00 PM
DONNELLY HOWARD WDirectorOct 17, 2013 Sale$15.0620,000301,20015,850Oct 21, 2013, 12:00 PM
SOTO JOHNSVP - Global Franchise LeaderSep 10, 2013 Option Exercise$11.2690510,19014,290Sep 11, 2013, 04:39 PM
DEVIVO JOSEPHPresident and CEOSep 09, 2013 Option Exercise$11.102,26125,09774,290Sep 11, 2013, 04:37 PM
Greiner Charles RVP - Global FranchiseSep 04, 2013 Option Exercise$10.967958,71325,520Sep 06, 2013, 05:06 PM
Richard StarkSVP, GM - OncologySep 04, 2013 Option Exercise$10.968359,15227,245Sep 06, 2013, 05:03 PM
Kapusta Matthew CSVP, Business DevelopmentAug 03, 2013 Option Exercise$12.045306,38119,112Aug 06, 2013, 09:32 PM
DEVIVO JOSEPHPresident and Chief ExecutiveAug 03, 2013 Option Exercise$12.042,35828,39058,213Aug 06, 2013, 09:31 PM
Greiner Charles RVP - Global FranchiseAug 03, 2013 Option Exercise$12.042,04524,62222,564Aug 06, 2013, 09:29 PM
McGill StephenSVP, GM - InternationalAug 03, 2013 Option Exercise$12.042,87834,65117,624Aug 06, 2013, 09:28 PM
Richard StarkSVP, GM - OncologyAug 03, 2013 Option Exercise$12.042,35828,39024,674Aug 06, 2013, 09:27 PM
Gould Kevin JDirectorJul 22, 2013 Buy$12.002,70032,40010,950Jul 23, 2013, 09:36 AM
Bourne George W. IVCTO and COOMay 21, 2013 Option Exercise$10.9694810,39011,963May 22, 2013, 05:45 PM
Greiner Charles RVP - Global FranchiseMay 09, 2013 Sale$10.381,49515,51823,221May 16, 2013, 02:36 PM
GOLD JEFFREYDirectorMar 25, 2013 Option Exercise$6.522,50816,35627,741Mar 27, 2013, 04:02 PM
BUCCI VINCENTDirectorMar 12, 2013 Buy$10.8010,000108,00013,000Mar 13, 2013, 03:33 PM
BUCCI VINCENTDirectorMar 12, 2013 Buy$10.7635,000376,60038,000Mar 13, 2013, 03:33 PM
BUCCI VINCENTDirectorMar 12, 2013 Buy$10.7840,000431,20078,696Mar 13, 2013, 03:33 PM
Meteny Dennis SDirectorMar 12, 2013 Buy$10.824,60049,77221,950Mar 12, 2013, 06:05 PM
BUCCI VINCENTDirectorFeb 14, 2013 Buy$12.172,00024,33238,696Feb 15, 2013, 06:00 PM
Richard StarkSVP, GM - OncologyJan 28, 2013 Option Exercise$12.3583810,34925,093Jan 30, 2013, 11:28 AM
McGill StephenSVP, GM - InternationalJan 28, 2013 Option Exercise$12.352,60032,11019,386Jan 30, 2013, 11:22 AM
Gould Kevin JDirectorJan 11, 2013 Buy$11.582,70031,2778,250Jan 14, 2013, 12:07 PM
Kapusta Matthew CSVP, Business DevelopmentNov 15, 2012 Option Exercise$10.121,35813,74319,642Nov 16, 2012, 09:38 AM
GOLD JEFFREYDirectorNov 05, 2012 Buy$10.561,00010,56025,233Nov 13, 2012, 10:08 AM
Richard StarkSVP, GM - OncologyNov 05, 2012 Sale$10.363,16032,73825,931Nov 09, 2012, 12:13 PM
GERSUK D JOSEPHEVP - CFOSep 04, 2012 Option Exercise$11.611,08612,60847,275Sep 11, 2012, 06:57 PM
Richard StarkSVP, GM - OncologySep 04, 2012 Option Exercise$11.617158,30129,091Sep 11, 2012, 06:54 PM
DEVIVO JOSEPHPresident and CEOSep 07, 2012 Option Exercise$12.122,52630,61560,571Sep 10, 2012, 06:24 PM
Richard StarkSVP, GM - OncologyAug 03, 2012 Option Exercise$10.701,11611,94120,565Aug 07, 2012, 08:29 AM
McGill StephenSVP, GM - InternationalAug 03, 2012 Option Exercise$10.7099710,6687,616Aug 07, 2012, 08:28 AM
GERSUK D JOSEPHEVP - CFOAug 03, 2012 Option Exercise$10.702,17223,24037,175Aug 07, 2012, 08:27 AM
Etlinger Richard ScottSVP - Global OperationsAug 23, 2012 Option Exercise$10.705435,8105,457Aug 07, 2012, 08:26 AM
DEVIVO JOSEPHPresident and CEOJul 17, 2012 Buy$11.672,00023,34038,000Jul 18, 2012, 02:30 PM
Richard StarkSVP, GM - OncologyMay 16, 2012 Sale$12.422,08025,82720,922May 17, 2012, 03:12 PM
BUCCI VINCENTDirectorApr 12, 2012 Buy$11.872,00023,73533,846May 15, 2012, 06:24 PM
ECHENBERG PAUL SDirector EmeritusApr 23, 2012 Option Exercise$6.522,09113,637154,412Apr 27, 2012, 07:15 PM
GOLD JEFFREYDirectorApr 25, 2012 Option Exercise$6.524182,72621,383Apr 27, 2012, 07:11 PM
BUCCI VINCENTDirectorApr 12, 2012 Buy$11.824,00047,2804,000Apr 13, 2012, 07:00 PM
Gould Kevin JDirectorApr 11, 2012 Buy$11.722,70031,6362,700Apr 12, 2012, 11:43 AM
DEVIVO JOSEPHPresident and CEOApr 09, 2012 Buy$11.825,00059,09436,000Apr 10, 2012, 02:27 PM
Kapusta Matthew CSVP, Business DevelopmentApr 10, 2012 Buy$11.401,00011,39716,000Apr 10, 2012, 02:22 PM
BUCCI VINCENTDirectorApr 09, 2012 Buy$11.802,00023,59631,846Apr 10, 2012, 02:16 PM
BUCCI VINCENTDirectorFeb 21, 2012 Buy$13.442,00026,87829,846Feb 21, 2012, 05:45 PM
BUCCI VINCENTDirectorFeb 15, 2012 Buy$13.252,00026,49427,846Feb 15, 2012, 02:36 PM
BUCCI VINCENTDirectorFeb 13, 2012 Buy$12.931,00012,92725,846Feb 15, 2012, 02:36 PM
DEVIVO JOSEPHPresident and CEOFeb 13, 2012 Buy$12.953,00038,85031,000Feb 13, 2012, 06:19 PM
DEVIVO JOSEPHPresident and CEONov 16, 2011 Buy$14.152,50035,36328,000Nov 17, 2011, 09:04 AM
GERSUK D JOSEPHEVP - CFOSep 06, 2011 Option Exercise$13.491,08614,65038,533Sep 08, 2011, 05:11 PM
GERSUK D JOSEPHEVP - CFOSep 06, 2011 Option Exercise$13.493,00040,47039,619Sep 08, 2011, 05:11 PM
Meteny Dennis SDirectorAug 31, 2011 Option Exercise$11.005,00055,00014,500Sep 01, 2011, 03:10 PM
BUCCI VINCENTDirectorAug 16, 2011 Buy$14.113,00042,3303,000Aug 17, 2011, 05:46 PM
BUCCI VINCENTDirectorAug 16, 2011 Buy$14.013,00042,0253,000Aug 17, 2011, 05:46 PM
McGill StephenSVP, GM - InternationalAug 03, 2011 Option Exercise$13.533674,9667,983Aug 05, 2011, 08:27 PM
GERSUK D JOSEPHEVP - CFOAug 03, 2011 Option Exercise$13.531,35818,37436,619Aug 05, 2011, 08:24 PM
Solano Scott J.Interim CEOAug 03, 2011 Option Exercise$13.531,67222,6228,945Aug 05, 2011, 08:12 PM
ECHENBERG PAUL SDirector EmeritusJun 01, 2011 Option Exercise$4.352,0919,091152,321Jun 03, 2011, 12:48 PM
McGill StephenSVP, GM - InternationalJan 28, 2011 Option Exercise$16.241,02516,64612,475Feb 02, 2011, 04:59 PM
Keltjens JanPresident & CEOJan 19, 2011 Option Exercise$16.569,094150,597109,276Jan 21, 2011, 12:29 PM
LaPorte SteveDirectorOct 19, 2010 Buy$14.295007,1438,013Oct 20, 2010, 04:55 PM
LaPorte SteveDirectorOct 19, 2010 Buy$14.295007,1438,013Oct 20, 2010, 04:48 PM
APPLING WILLIAM MVice-President - ResearchSep 07, 2010 Option Exercise$15.232,25034,26716,636Sep 07, 2010, 05:56 PM
GERSUK D JOSEPHEVP - CFOSep 07, 2010 Option Exercise$15.231,08616,54027,565Sep 07, 2010, 05:49 PM
GERSUK D JOSEPHEVP - CFOSep 07, 2010 Option Exercise$15.233,00045,69028,651Sep 07, 2010, 05:49 PM
MAPES HAROLDVP - OperationsSep 07, 2010 Option Exercise$15.234526,88413,684Sep 07, 2010, 05:43 PM
MAPES HAROLDVP - OperationsSep 07, 2010 Option Exercise$15.231,25019,03714,934Sep 07, 2010, 05:43 PM
McCarthy Shawn PSVP - General ManagerAug 17, 2010 Option Exercise$16.041,35821,78210,392Aug 30, 2010, 05:27 PM
McCarthy Shawn PSVP - General ManagerAug 17, 2010 Option Exercise$16.041,59025,5046,410Aug 17, 2010, 05:27 PM
Keltjens JanPresident & CEOJan 19, 2010 Option Exercise$17.228,149140,32696,851Aug 05, 2010, 03:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Trowbridge Stephen AEVP and CFO02/29/20248,999
Trowbridge Stephen AEVP and CFO07/19/202362,217
Helsel DaveSVP Global Operations and R&D07/19/202331,015
Centea ScottSVP/GM, VIT07/19/202324,227
Campbell Chad ThomasSVP/GM, Vascular Access07/19/202327,679
Clemmer James CPresident and CEO07/19/2023305,920
Clemmer James CPresident and CEO07/19/2023101,501
Helsel DaveSVP Global Operations and R&D07/19/202314,049
Campbell Chad ThomasSVP/GM, Vascular Access07/19/202312,524
Centea ScottSVP/GM, VIT07/19/202310,972
Trowbridge Stephen AEVP and CFO07/19/202328,178
Trowbridge Stephen AEVP and CFO07/21/20235,770
Trowbridge Stephen AEVP and CFO07/20/20236,267
Clemmer James CPresident and CEO07/21/202329,168
Clemmer James CPresident and CEO07/20/202326,063
Helsel DaveSVP Global Operations and R&D07/20/20232,902
Helsel DaveSVP Global Operations and R&D07/21/20233,157
Centea ScottSVP/GM, VIT07/21/20232,206
Centea ScottSVP/GM, VIT07/20/20232,910
Piccinini LauraSVP International07/21/20233,572
Piccinini LauraSVP International07/20/20235,384
Campbell Chad ThomasSVP/GM, Vascular Access07/21/20233,417
Campbell Chad ThomasSVP/GM, Vascular Access07/20/20233,138
Trowbridge Stephen AEVP and CFO07/14/202313,116
Trowbridge Stephen AEVP and CFO07/17/20233,595
Clemmer James CPresident and CEO07/17/202321,625
Clemmer James CPresident and CEO07/14/202347,245
Campbell Chad ThomasSVP/GM, Vascular Access07/17/20232,667
Campbell Chad ThomasSVP/GM, Vascular Access07/14/20235,739
Centea ScottSVP/GM, VIT07/14/20234,979
Centea ScottSVP/GM, VIT07/17/20233,356
Helsel DaveSVP Global Operations and R&D07/17/20232,992
Helsel DaveSVP Global Operations and R&D07/14/20236,539
Piccinini LauraSVP International06/01/202313,496
Trowbridge Stephen AEVP and CFO02/03/20237,454
ROSENZWEIG RICHARD CSVP and General Counsel02/01/202315,190
Helsel DaveSVP Global Operations and R&D01/31/202359,997
Trowbridge Stephen AEVP and CFO10/12/202214,967
Clemmer James CPresident and CEO10/10/2022150,000
Helsel DaveSVP Global Operations and R&D07/29/2022112,200
JOHNSON WESLEYDirector07/15/202296,047
JOHNSON WESLEYDirector07/15/202296,051
Trowbridge Stephen AEVP and CFO07/15/2022264,325
Trowbridge Stephen AEVP and CFO07/15/2022235,390
Meteny Dennis SDirector07/12/202296,056
Meteny Dennis SDirector07/12/202296,051
Helsel DaveSVP Global Operations and R&D07/07/202225,120
Campbell Chad ThomasSVP/GM, Vascular Access07/07/202222,142
Nighan Warren JRSVP Quality and Regulatory07/07/202218,876
Trowbridge Stephen AEVP and CFO07/07/202230,995
Clemmer James CPresident and CEO07/07/2022176,110
Helsel DaveSVP Global Operations and R&D04/28/202278,832
DONNELLY HOWARD WDirector04/20/202296,051
JOHNSON WESLEYDirector04/12/202230,215
JOHNSON WESLEYDirector04/11/2022142,623
Trowbridge Stephen AEVP and CFO02/03/202211,940
ROSENZWEIG RICHARD CSVP and General Counsel02/01/202225,444
Trowbridge Stephen AEVP and CFO01/12/202222,640
Clemmer James CPresident and CEO01/11/2022228,400
Centea ScottSr. VP/GM, Global VIT10/31/202127,990
Helsel DaveSVP Global Operations and R&D10/20/202197,727
Centea ScottSr. VP/GM, Global VIT10/15/2021201,240
Centea ScottSr. VP/GM, Global VIT10/15/2021335,040
Campbell Chad ThomasSVP/GM, Vascular Access10/05/2021178,309
Campbell Chad ThomasSVP/GM, Vascular Access10/05/2021291,808
Campbell Chad ThomasSVP/GM, Vascular Access08/12/202185,418
Clemmer James CPresident and CEO08/12/2021587,608
Trowbridge Stephen AEVP and CFO08/12/2021113,881
Helsel DaveSVP Global Operations and R&D08/12/202191,340
Helsel DaveSVP Global Operations and R&D08/12/202121,505
Clemmer James CPresident and CEO08/12/2021246,183
Campbell Chad ThomasSVP/GM, Vascular Access08/12/202119,158
Trowbridge Stephen AEVP and CFO08/12/202133,594
Meteny Dennis SDirector07/28/202183,810
Meteny Dennis SDirector07/28/202183,829
JOHNSON WESLEYDirector07/28/202183,810
JOHNSON WESLEYDirector07/28/202183,829
Centea ScottSr. VP/GM, Global VIT07/26/202110,936
Campbell Chad ThomasSVP/GM, Vascular Access07/26/20218,300
Trowbridge Stephen AEVP and CFO07/26/20219,213
Clemmer James CPresident and CEO07/26/202154,941
Trowbridge Stephen AEVP and CFO07/17/20218,765
Trowbridge Stephen AEVP and CFO07/14/202133,936
Trowbridge Stephen AEVP and CFO07/18/20219,904
Helsel DaveSVP Global Operations and R&D07/18/202110,325
Helsel DaveSVP Global Operations and R&D07/17/20217,279
Helsel DaveSVP Global Operations and R&D07/14/202116,915
Centea ScottSVP/GM, VIT07/14/202113,215
Centea ScottSVP/GM, VIT07/18/20218,517
Centea ScottSVP/GM, VIT07/17/20218,394
Campbell Chad ThomasSVP/GM, Vascular Access07/18/20217,428
Campbell Chad ThomasSVP/GM, Vascular Access07/17/20216,487
Campbell Chad ThomasSVP/GM, Vascular Access07/14/202115,092
Clemmer James CPresident and CEO07/14/2021122,159
Clemmer James CPresident and CEO07/18/202136,719
Clemmer James CPresident and CEO07/17/202152,764
Helsel DaveSVP Global Operations and R&D04/14/202183,755
DONNELLY HOWARD WDirector04/01/202183,826
DONNELLY HOWARD WDirector04/01/202183,829
Trowbridge Stephen AEVP and CFO02/03/202110,139
JOHNSON WESLEYDirector01/20/2021120,445
Helsel DaveSVP Global Operations and R&D12/18/202010,475
Centea ScottSVP/GM, VIT10/31/20209,016
Trowbridge Stephen AEVP and CFO08/11/20209,502
Clemmer James CPresident and CEO07/31/2020330,400
Trowbridge Stephen AEVP and CFO07/27/20202,570
Trowbridge Stephen AEVP and CFO07/26/20202,763
Clemmer James CPresident and CEO07/26/202016,509
Clemmer James CPresident and CEO07/27/202015,831
Campbell Chad ThomasSVP/GM, Vascular Access07/27/20202,279
Campbell Chad ThomasSVP/GM, Vascular Access07/26/20202,490
Trowbridge Stephen AEVP and CFO07/18/20203,684
Trowbridge Stephen AEVP and CFO07/17/20203,349
Helsel DaveSVP Global Operations and R&D07/17/20202,403
Helsel DaveSVP Global Operations and R&D07/18/20203,334
Clemmer James CPresident and CEO07/18/202013,658
Clemmer James CPresident and CEO07/17/202020,159
Campbell Chad ThomasSVP/GM, Vascular Access07/18/20202,763
Campbell Chad ThomasSVP/GM, Vascular Access07/17/20202,479
Campbell Chad ThomasSVP/GM, Vascular Access05/23/20209,259
Clemmer James CPresident and CEO04/04/202043,426
Boucher Brent J.SVP and GM of Oncology02/12/20206,365
Boucher Brent J.SVP and GM of Oncology01/17/20207,585
Helsel DaveSVP Global Operations and R&D12/18/201911,460
Clemmer James CPresident and CEO10/25/2019212,850
Greiner MichaelEVP and CFO08/18/201915,777
Trowbridge Stephen ASVP and General Counsel07/12/201925,691
Greiner MichaelEVP and CFO07/12/201974,579
Simpson Robert ArthurSVP/GM, Global Vascular07/12/2019111,825
Clemmer James CPresident and CEO07/12/20192,084,315
Campbell Chad ThomasSVP/GM, Vascular Access07/12/201922,764
JOHNSON WESLEYDirector08/06/201971,011
JOHNSON WESLEYDirector08/06/201971,022
Clemmer James CPresident and CEO07/26/201938,145
Clemmer James CPresident and CEO07/27/201936,634
Campbell Chad ThomasSVP/GM, Vascular Access07/27/20195,269
Campbell Chad ThomasSVP/GM, Vascular Access07/26/20195,766
Simpson Robert ArthurSVP/GM, Global Vascular07/26/20196,455
Trowbridge Stephen ASVP and General Counsel07/27/20195,959
Trowbridge Stephen ASVP and General Counsel07/26/20196,392
Trowbridge Stephen ASVP and General Counsel07/22/20197,590
Greiner MichaelEVP and CFO07/26/201910,675
Greiner MichaelEVP and CFO07/18/201912,401
Clemmer James CPresident and CEO07/18/201931,089
Campbell Chad ThomasSVP/GM, Vascular Access07/18/20196,287
Trowbridge Stephen ASVP and General Counsel07/22/20197,590
Trowbridge Stephen ASVP and General Counsel07/18/20198,375
Boucher Brent J.SVP and GM of Oncology07/18/20198,031
Helsel DaveSVP Global Operations and R&D07/18/20198,720
Simpson Robert ArthurSVP/GM, Global Vascular07/18/20198,440
GOLD JEFFREYDirector07/12/201971,024
GOLD JEFFREYDirector07/12/201971,022
Gould Kevin JDirector07/16/2019154,462
Gould Kevin JDirector07/16/2019292,793
Meteny Dennis SDirector06/28/201971,022
Meteny Dennis SDirector06/28/201971,022
Meteny Dennis SDirector05/31/201971,026
Meteny Dennis SDirector05/31/201971,022
Campbell Chad ThomasSVP/GM, Vascular Access05/23/201916,431
Trowbridge Stephen ASVP and General Counsel04/24/201927,224
Clemmer James CPresident and CEO04/04/201997,124
Boucher Brent J.SVP and GM of Oncology02/12/201911,221
Simpson Robert ArthurSVP/GM, Global Vascular01/31/201920,699
Greiner MichaelEVP and CFO11/07/201841,747
Trowbridge Stephen ASVP and General Counsel07/12/201824,088
Trowbridge Stephen ASVP and General Counsel07/27/20186,105
Clemmer James CPresident and CEO07/27/201837,528
Campbell Chad ThomasSVP/GM, Vascular Access07/27/20185,398
Trowbridge Stephen ASVP and General Counsel07/26/20186,695
Trowbridge Stephen ASVP and General Counsel07/25/20188,407
Trowbridge Stephen ASVP and General Counsel07/22/20187,693
Campbell Chad ThomasSVP/GM, Vascular Access07/26/20186,039
Greiner MichaelEVP and CFO07/26/201811,181
Clemmer James CPresident and CEO07/26/201839,953
Simpson Robert ArthurSVP/GM, Global Vascular07/26/20186,739
GOLD JEFFREYDirector07/06/201894,695
GOLD JEFFREYDirector07/06/201894,710
Meteny Dennis SDirector06/21/2018189,414
Meteny Dennis SDirector06/21/2018189,420
DONNELLY HOWARD WDirector06/21/201871,030
DONNELLY HOWARD WDirector06/21/201871,022
GOLD JEFFREYDirector06/21/201894,707
GOLD JEFFREYDirector06/21/201894,710
JOHNSON WESLEYDirector06/22/2018189,424
JOHNSON WESLEYDirector06/22/2018189,420
Campbell Chad ThomasSVP/GM, Vascular Access05/23/201816,846
Trowbridge Stephen ASVP and General Counsel04/24/201825,293
Simpson Robert ArthurSVP/GM, Global Vascular01/31/201818,385
DONNELLY HOWARD WDirector11/21/2017189,408
DONNELLY HOWARD WDirector11/21/2017189,420
Richard StarkSVP, GM - Oncology11/15/2017313,815
Richard StarkSVP, GM - Oncology11/15/2017446,493
Gould Kevin JDirector09/12/2017547,168
Gould Kevin JDirector09/12/2017547,170
Trowbridge Stephen ASVP and General Counsel08/06/20178,197
JOHNSON WESLEYDirector07/25/2017220,488
JOHNSON WESLEYDirector07/25/2017220,500
Richard StarkSVP, GM - Oncology08/06/20178,313
Meteny Dennis SDirector07/25/2017220,488
Meteny Dennis SDirector07/25/2017220,500
Clemmer James CPresident and CEO07/27/201732,033
Campbell Chad ThomasSVP/GM, Vascular Access07/27/20174,614
GOLD JEFFREYDirector07/25/2017220,488
GOLD JEFFREYDirector07/25/2017220,500
Richard StarkSVP, GM - Oncology07/25/20177,396
Richard StarkSVP, GM - Oncology07/22/20176,602
Trowbridge Stephen ASVP and General Counsel07/25/20177,481
Trowbridge Stephen ASVP and General Counsel07/22/20176,670
REED JAN STERNDirector07/24/20175,056
DONNELLY HOWARD WDirector07/21/201778,600
Clemmer James CPresident and CEO07/21/201778,950
Clemmer James CPresident and CEO07/20/2017312,800
DONNELLY HOWARD WDirector06/19/2017220,496
DONNELLY HOWARD WDirector06/19/2017220,500
Campbell Chad ThomasSVP/GM, Vascular Access05/23/201712,466
Trowbridge Stephen ASVP and General Counsel04/24/201725,011
Burgstahler David FDirector04/12/201737,600,000
Avista Capital Partners GP, LLC10% Owner04/12/201737,600,000
Clemmer James CPresident and CEO04/04/201776,906
LaPorte SteveDirector01/13/2017250,880
LaPorte SteveDirector01/13/2017220,500
Burgstahler David FDirector11/18/20166,408,510
Burgstahler David FDirector11/18/201632,791,491
Avista Capital Partners GP, LLC10% Owner11/18/20166,408,510
Avista Capital Partners GP, LLC10% Owner11/18/201632,791,491
Meteny Dennis SDirector08/31/2016159,479
Meteny Dennis SDirector08/31/2016159,480
GOLD JEFFREYDirector08/31/2016159,479
GOLD JEFFREYDirector08/31/2016159,480
Trowbridge Stephen ASVP and General Counsel07/11/201624,587
Trowbridge Stephen ASVP and General Counsel08/08/20167,699
Burgstahler David FDirector08/05/201632,895,000
Avista Capital Partners GP, LLC10% Owner08/05/201632,763,420
Trowbridge Stephen ASVP and General Counsel07/25/20167,239
Trowbridge Stephen ASVP and General Counsel07/22/20166,591
DONNELLY HOWARD WDirector07/15/2016159,473
DONNELLY HOWARD WDirector07/15/2016159,480
JOHNSON WESLEYDirector07/15/2016159,473
JOHNSON WESLEYDirector07/15/2016159,480
LaPorte SteveDirector07/13/2016159,480
LaPorte SteveDirector07/13/2016159,480
Greiner Charles RVP - Global Franchise05/06/201643,183
Trowbridge Stephen ASVP and General Counsel04/25/201616,608
Trowbridge Stephen ASVP and General Counsel04/21/2016129,465
Trowbridge Stephen ASVP and General Counsel04/25/201629,719
SOTO JOHNSVP and CCO09/10/201511,840
DEVIVO JOSEPHPresident and CEO09/08/201533,686
SOTO JOHNSVP and CCO08/06/20157,828
Trowbridge Stephen ASVP and General Counsel08/06/20157,716
Greiner Charles RVP - Global Franchise08/06/20157,398
Richard StarkSVP, GM - Oncology08/06/20157,589
Frost Mark TEVP and CFO08/06/201512,680
DEVIVO JOSEPHPresident and CEO08/06/201526,411
Meteny Dennis SDirector08/05/201591,619
Meteny Dennis SDirector08/05/201591,620
JOHNSON WESLEYDirector08/05/201591,619
JOHNSON WESLEYDirector08/05/201591,620
GOLD JEFFREYDirector08/05/201591,619
GOLD JEFFREYDirector08/05/201591,620
LaPorte SteveDirector08/05/201591,619
LaPorte SteveDirector08/05/201591,620
Richard StarkSVP, GM - Oncology08/03/201525,672
DEVIVO JOSEPHPresident and CEO08/03/201531,298
Greiner Charles RVP - Global Franchise08/03/201518,555
Greiner Charles RVP - Global Franchise08/05/2015218,067
Greiner Charles RVP - Global Franchise08/05/2015215,307
Trowbridge Stephen ASVP and General Counsel08/05/201589,706
Trowbridge Stephen ASVP and General Counsel08/03/201520,388
Trowbridge Stephen ASVP and General Counsel08/05/201588,566
Frost Mark TEVP and CFO07/27/201510,878
DEVIVO JOSEPHPresident and CEO07/27/201543,701
SOTO JOHNSVP and CCO07/27/20158,847
Greiner Charles RVP - Global Franchise07/27/20156,424
Richard StarkSVP, GM - Oncology07/27/20156,580
Trowbridge Stephen ASVP and General Counsel07/27/20156,690
DONNELLY HOWARD WDirector07/16/201591,620
JOHNSON WESLEYDirector06/08/201576,941
Richard StarkSVP, GM - Oncology02/13/2015276,387
Richard StarkSVP, GM - Oncology02/13/2015335,393
Richard StarkSVP, GM - Oncology01/28/20158,137
Frost Mark TEVP and CFO12/01/201432,387
Kapusta Matthew CSVP, Business Development11/17/201423,455
Greiner Charles RVP - Global Franchise10/20/201451,548
SOTO JOHNEVP and CCO09/10/201410,902
DEVIVO JOSEPHPresident and CEO09/08/201431,436
GOLD JEFFREYDirector07/07/201485,939
GOLD JEFFREYDirector07/07/201479,080
Bourne George W. IVCTO and COO08/06/20148,467
Greiner Charles RVP - Global Franchise08/06/20146,859
Greiner Charles RVP - Global Franchise08/03/201427,191
Richard StarkSVP, GM - Oncology08/06/20147,036
Richard StarkSVP, GM - Oncology08/03/201429,512
Kapusta Matthew CSVP, Business Development08/06/20148,496
Kapusta Matthew CSVP, Business Development08/03/20147,786
DEVIVO JOSEPHPresident and CEO08/06/201424,485
DEVIVO JOSEPHPresident and CEO08/03/201429,586
Frost Mark TEVP and CFO08/06/201411,756
SOTO JOHNSVP - Global Franchise Leader08/06/20148,113
Bourne George W. IVCTO and COO05/21/201413,386
Meteny Dennis SDirector04/14/2014170,500
Kapusta Matthew CSVP, Business Development04/14/201413,900
Richard StarkSVP, GM - Oncology01/28/20145,951
McGill StephenSVP, GM - International01/28/201419,587
Bourne George W. IVCTO and COO12/17/20132,548
Kapusta Matthew CSVP, Business Development11/15/201321,743
Greiner Charles RVP - Global Finance11/14/201357,636
Greiner Charles RVP - Global Finance11/13/201336,842
Greiner Charles RVP - Global Finance11/14/201367,611
BUCCI VINCENTDirector10/18/201375,990
DONNELLY HOWARD WDirector10/17/2013220,000
DONNELLY HOWARD WDirector10/17/2013301,200
SOTO JOHNSVP - Global Franchise Leader09/10/201310,190
DEVIVO JOSEPHPresident and CEO09/09/201325,097
Greiner Charles RVP - Global Franchise09/04/20138,713
Richard StarkSVP, GM - Oncology09/04/20139,152
Kapusta Matthew CSVP, Business Development08/03/20136,381
DEVIVO JOSEPHPresident and Chief Executive08/03/201328,390
Greiner Charles RVP - Global Franchise08/03/201324,622
McGill StephenSVP, GM - International08/03/201334,651
Richard StarkSVP, GM - Oncology08/03/201328,390
Gould Kevin JDirector07/22/201332,400
Bourne George W. IVCTO and COO05/21/201310,390
Greiner Charles RVP - Global Franchise05/09/201315,518
GOLD JEFFREYDirector03/25/201316,356
BUCCI VINCENTDirector03/12/2013108,000
BUCCI VINCENTDirector03/12/2013376,600
BUCCI VINCENTDirector03/12/2013431,200
Meteny Dennis SDirector03/12/201349,772
BUCCI VINCENTDirector02/14/201324,332
Richard StarkSVP, GM - Oncology01/28/201310,349
McGill StephenSVP, GM - International01/28/201332,110
Gould Kevin JDirector01/11/201331,277
Kapusta Matthew CSVP, Business Development11/15/201213,743
GOLD JEFFREYDirector11/05/201210,560
Richard StarkSVP, GM - Oncology11/05/201232,738
GERSUK D JOSEPHEVP - CFO09/04/201212,608
Richard StarkSVP, GM - Oncology09/04/20128,301
DEVIVO JOSEPHPresident and CEO09/07/201230,615
Richard StarkSVP, GM - Oncology08/03/201211,941
McGill StephenSVP, GM - International08/03/201210,668
GERSUK D JOSEPHEVP - CFO08/03/201223,240
Etlinger Richard ScottSVP - Global Operations08/23/20125,810
DEVIVO JOSEPHPresident and CEO07/17/201223,340
Richard StarkSVP, GM - Oncology05/16/201225,827
BUCCI VINCENTDirector04/12/201223,735
ECHENBERG PAUL SDirector Emeritus04/23/201213,637
GOLD JEFFREYDirector04/25/20122,726
BUCCI VINCENTDirector04/12/201247,280
Gould Kevin JDirector04/11/201231,636
DEVIVO JOSEPHPresident and CEO04/09/201259,094
Kapusta Matthew CSVP, Business Development04/10/201211,397
BUCCI VINCENTDirector04/09/201223,596
BUCCI VINCENTDirector02/21/201226,878
BUCCI VINCENTDirector02/15/201226,494
BUCCI VINCENTDirector02/13/201212,927
DEVIVO JOSEPHPresident and CEO02/13/201238,850
DEVIVO JOSEPHPresident and CEO11/16/201135,363
GERSUK D JOSEPHEVP - CFO09/06/201114,650
GERSUK D JOSEPHEVP - CFO09/06/201140,470
Meteny Dennis SDirector08/31/201155,000
BUCCI VINCENTDirector08/16/201142,330
BUCCI VINCENTDirector08/16/201142,025
McGill StephenSVP, GM - International08/03/20114,966
GERSUK D JOSEPHEVP - CFO08/03/201118,374
Solano Scott J.Interim CEO08/03/201122,622
ECHENBERG PAUL SDirector Emeritus06/01/20119,091
McGill StephenSVP, GM - International01/28/201116,646
Keltjens JanPresident & CEO01/19/2011150,597
LaPorte SteveDirector10/19/20107,143
LaPorte SteveDirector10/19/20107,143
APPLING WILLIAM MVice-President - Research09/07/201034,267
GERSUK D JOSEPHEVP - CFO09/07/201016,540
GERSUK D JOSEPHEVP - CFO09/07/201045,690
MAPES HAROLDVP - Operations09/07/20106,884
MAPES HAROLDVP - Operations09/07/201019,037
McCarthy Shawn PSVP - General Manager08/17/201021,782
McCarthy Shawn PSVP - General Manager08/17/201025,504
Keltjens JanPresident & CEO01/19/2010140,326
Load More Insider Transactions
FUNDS WITH A POSITION IN ANGIODYNAMIC INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,044,0980.00101%21.2%Other
GEODE CAPITAL MANAGEMENT, LLC896,8080.00074%5.84%Other
RENAISSANCE TECHNOLOGIES LLC864,0830.01%31.26%Other
AQR CAPITAL MANAGEMENT LLC694,2260.01%211.09%Other
D. E. SHAW & CO., INC.604,4510.00414%-11.89%Other
BALYASNY ASSET MANAGEMENT L.P.116,5960.00174%ExitedEvent Driven
TUDOR INVESTMENT CORP ET AL99,3800.00627%0.35%Event Driven, Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)15,3520.00222%NewOther
CHANGE IN SHARES OUTSTANDING FOR ANGIODYNAMIC INC
STOCK BUYBACKS FOR ANGIODYNAMIC INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
11/30/2023
08/31/2023
0.63%
1Q
11/30/2023
05/31/2023
1.53%
2Q
11/30/2023
02/28/2023
1.80%
3Q
11/30/2023
11/30/2022
1.85%
4Q
11/30/2023
08/31/2022
2.33%
5Q
11/30/2023
05/31/2022
2.71%
6Q
11/30/2023
02/28/2022
2.88%
7Q
11/30/2023
11/30/2021
2.99%
8Q
11/30/2023
08/31/2021
3.83%
9Q
11/30/2023
05/31/2021
4.40%
10Q
11/30/2023
02/28/2021
4.85%
11Q
11/30/2023
11/30/2020
4.94%
12Q
11/30/2023
08/31/2020
5.40%
13Q
11/30/2023
05/31/2020
5.64%
14Q
11/30/2023
02/29/2020
5.84%
15Q
11/30/2023
11/30/2019
5.86%
16Q
Load More

Period of Report: 11/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
08/31/2023
0.63%
1Q
05/31/2023
1.53%
2Q
02/28/2023
1.80%
3Q
11/30/2022
1.85%
4Q
08/31/2022
2.33%
5Q
05/31/2022
2.71%
6Q
02/28/2022
2.88%
7Q
11/30/2021
2.99%
8Q
08/31/2021
3.83%
9Q
05/31/2021
4.40%
10Q
02/28/2021
4.85%
11Q
11/30/2020
4.94%
12Q
08/31/2020
5.40%
13Q
05/31/2020
5.64%
14Q
02/29/2020
5.84%
15Q
11/30/2019
5.86%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANGIODYNAMIC INC
LOADING...